AstraZeneca quarterly product sales beat on cancer drug strength [Reuters (UK)]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Reuters
AstraZeneca lifts sales outlook after second quarter cancer drug boost - Reuters 2 Min Read (Reuters) - AstraZeneca Plc ( AZN.L ) forecast higher product sales for the whole of 2019 after its second-quarter results beat analysts’ expectations on Thursday, driven by sales from cancer medicines including a near doubling of those for its Tagrisso treatment. The British drugmaker has banked on oncology treatments as well as emerging markets to return it to growth after years of crumbling sales due to patent losses on older drugs. In the second quarter, sales from its oncology unit soared 57% to $2.17 billion, accounting for 38% of total product sales. Tagrisso brought in sales of $784 million. Core earnings were 73 cents per share, beating analysts’ average expectation of 61 cents per share, according to a company provided consensus. Full-year product sales are now expected to increase by a low double-digit percentage, the company said, compared to a previous forecast of high single-dig
Show less
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Why Astrazeneca (AZN) Outpaced the Stock Market Today [Yahoo! Finance]Yahoo! Finance
- Merck-AstraZeneca breast cancer drug reduces risk of death by 28% in patients diagnosed early, clinical trial shows [Fortune]Fortune
- Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]Yahoo! Finance
- 8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030 [Yahoo! Finance]Yahoo! Finance
- Ionis Gets FDA Approval for Rare Disease Drug Tryngolza [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 12/16/24 - Form 6-K
- 12/5/24 - Form 6-K
- 12/4/24 - Form 6-K
- AZN's page on the SEC website